Skip to content

Assessment of Serological Techniques for Screening Patients Regarding COVID-19-COVID-SER

Assessment of Serological Techniques for Screening Patients Regarding COVID-19-COVID-SER

Status
Active, not recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04341142
Acronym
COVID-SER
Enrollment
550
Registered
2020-04-10
Start date
2020-04-10
Completion date
2026-10-10
Last updated
2024-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

CoV2 Positive Caregivers

Brief summary

Covid-SER is a prospective multi-center study for the evaluation of diagnostic performance of available serological tests

Interventions

DIAGNOSTIC_TESTSerological tests will be applied on patients blood sampling

Application of tests on patients' serum

Sponsors

Hospices Civils de Lyon
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Seropositive caregivers screened for anti-SARS CoV2 antibodies during their consultation at the occupational medicine of HCL. * Age: ≥ 18 years old * Persons having given their written consent and accepting a follow-up every 6 months for 24 months, followed by a final visit at 36 months. * Persons affiliated to a social security scheme or beneficiary of such a scheme.

Exclusion criteria

* Pregnant or lactating woman

Design outcomes

Primary

MeasureTime frameDescription
The positivity (Yes/No) of the serological test.Day 0The sensitivity and specificity of serological tests (positive or negative) compared to molecular detection of the virus by PCR

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 17, 2026